Allied Biotech (1780) reported revenue of NT$104.4 million for Oct 2026, +29.0% year on year and +18.3% from the previous month. Revenue for Jan–Oct 2026 was NT$848.4 million (+18.4% year on year).
Revenue for Oct 2026 was a record high (previous high: Apr 2026, NT$103.2 million). →
Year-on-year revenue growth: 4 months in a row. →
In Oct 2026, it ranked No. 26 by revenue among 34 Food companies.
Monthly revenue chart
Hover over (or tap) a bar to see that month’s revenue.
Monthly revenue history
| Month | Revenue | YoY | MoM |
|---|---|---|---|
| Oct 2026 | NT$104.4 million | +29.0% | +18.3% |
| Sep 2026 | NT$88.2 million | +24.1% | +17.9% |
| Aug 2026 | NT$74.8 million | +12.5% | -9.3% |
| Jul 2026 | NT$82.5 million | +13.8% | +31.6% |
| Jun 2026 | NT$62.7 million | -6.4% | -32.0% |
| May 2026 | NT$92.2 million | +57.0% | -10.6% |
| Apr 2026 | NT$103.2 million | +14.7% | +41.8% |
| Mar 2026 | NT$72.8 million | +28.0% | -22.2% |
| Feb 2026 | NT$93.6 million | +17.8% | +26.6% |
| Jan 2026 | NT$73.9 million | +0.7% | +11.0% |
| Dec 2025 | NT$66.6 million | +3.1% | +0.3% |
| Nov 2025 | NT$66.4 million | -4.9% | -18.0% |
| Oct 2025 | NT$81 million | +56.1% | +13.9% |
| Sep 2025 | NT$71.1 million | +17.2% | +6.8% |
| Aug 2025 | NT$66.5 million | +14.4% | -8.3% |
| Jul 2025 | NT$72.5 million | -2.0% | +8.2% |
| Jun 2025 | NT$67.1 million | +9.6% | +14.2% |
| May 2025 | NT$58.7 million | -12.9% | -34.7% |
| Apr 2025 | NT$89.9 million | +38.0% | +58.2% |
| Mar 2025 | NT$56.9 million | -25.7% | -28.5% |
| Feb 2025 | NT$79.5 million | +9.8% | +8.3% |
| Jan 2025 | NT$73.4 million | -13.9% | +13.7% |
| Dec 2024 | NT$64.5 million | +65.0% | -7.5% |
| Nov 2024 | NT$69.8 million | +22.2% | +34.5% |
| Oct 2024 | NT$51.9 million | -21.4% | -14.4% |
Jan–Oct 2026 cumulative: NT$848.4 million (+18.4% YoY)
Other Food companies
Compare with peers: Allied Biotech vs UNI-PRESIDENT / Allied Biotech vs GREATWALL / Allied Biotech vs CPE
| Company | Revenue | YoY |
|---|---|---|
| UNI-PRESIDENT | NT$57.1 billion | +5.3% |
| GREATWALL | NT$9.66 billion | +14.6% |
| CPE | NT$2.66 billion | +13.4% |
| TTET | NT$2.48 billion | +33.4% |
| SFC | NT$2.08 billion | -3.5% |
| WEI CHUAN | NT$1.88 billion | +4.4% |
| NAMCHOW | NT$1.87 billion | +3.1% |
| LHIHC | NT$1.1 billion | +8.0% |
See also
← All Taiwan listed & OTC companies
Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16